Researchers have found in a new study that the combination of activated platelet‑rich plasma (PRP) and endovascular angioplasty improved microcirculation and tissue repair in diabetic foot ulcers, suggesting a promising new treatment option for patients with diabetic foot complications. The study, published in the World Journal of Diabetes, evaluated both laboratory (in vitro) and clinical outcomes following the use of PRP alongside angioplasty in individuals with ischemic diabetic foot ulcers. By simultaneously enhancing blood flow and delivering growth-factor–rich plasma, the dual treatment addresses both vascular insufficiency and impaired tissue regeneration, which are critical challenges in diabetic foot management.

In the experimental phase, the authors observed that activated PRP s

See Full Page